Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0K7DV
|
|||
Former ID |
DIB000778
|
|||
Drug Name |
Kevetrin
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Ovarian cancer [ICD-11: 2C73; ICD-10: C56; ICD-9: 183] | Phase 2 | [1] | |
Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 1 | [2] | ||
Company |
Cellceutix Corp
|
|||
Structure |
Download2D MOL |
|||
Formula |
C5H9N3S
|
|||
Canonical SMILES |
C(CC#N)CSC(=N)N
|
|||
InChI |
1S/C5H9N3S/c6-3-1-2-4-9-5(7)8/h1-2,4H2,(H3,7,8)
|
|||
InChIKey |
PRDJGNVQBVXXEO-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 500863-50-3
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800028294) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.